TPG-linked holders sell 13.6M LifeStance shares
LifeStance Health Group, Inc. reported that entities associated with TPG sold 13,643,207 shares of Common Stock at $10.62 per share in an indirect transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. reported that entities associated with TPG sold 13,643,207 shares of Common Stock at $10.62 per share in an indirect transaction. After this sale, TPG VIII Lynnwood Holdings Aggregation, L.P. directly holds 98,101,407 LifeStance common shares. The reporting persons are treated as indirect holders through a multi‑entity ownership chain and each disclaims beneficial ownership beyond any pecuniary interest.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 13,643,207 | $10.62 | $144.89M |
Footnotes (3)
- F1. Each of James G. Coulter and Jon Winkelried own entities that control TPG GP A, LLC (together with Messrs. Coulter and Winkelried, the "Reporting Persons"), which exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., which is the sole member of TPG GPCo, LLC, which is the sole member of TPG Holdings II-A, LLC, which is the general partner of TPG Operating Group II, L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Operating Group I, L.P., which is the sole member of TPG GenPar VIII Advisors, LLC, which is the general partner of TPG GenPar VIII, L.P., which is the general partner of TPG VIII Lynnwood Holdings Aggregation, L.P. ("TPG VIII Lynnwood"), which directly holds 98,101,407 shares of Common Stock of LifeStance Health Group, Inc.
- F2. Because of the relationship between the Reporting Persons and TPG VIII Lynnwood, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG VIII Lynnwood. Each of TPG VIII Lynnwood and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG VIII Lynnwood's or such Reporting Person's pecuniary interest therein, if any.
- F3. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
Key Figures
Key Terms
beneficial ownership regulatory
pecuniary interests financial
combined voting power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LifeStance Health Group (LFST) disclose in this Form 4?
Who are the reporting persons in the LifeStance (LFST) Form 4 filing?
Was the LifeStance (LFST) insider sale under a Rule 10b5-1 trading plan?
How is the LifeStance (LFST) ownership structured through TPG entities?
AI-generated analysis. How Rhea-AI works. Not financial advice.